For the Inventor, By the Inventor

Enter assignee name

Winnipeg, Canada

Cangene Corporation

USPTO Granted Patents = 13

CIPO Patents = 2

EPO Patents = 1

Trademarks = 8

Forward Citations = 1,484

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Lawrence T Malek (8 out of 14 patents)

David L Jenish (3 out of 3 patents)

Michael J Butler (3 out of 3 patents)

4. Gisela Soostmeyer (3 out of 3 patents)

5. Timothy J Krieger (3 out of 3 patents)

6. Robert T Garvin (3 out of 4 patents)

7. Dany Hadary (3 out of 4 patents)

8. Daniel Bartfeld (3 out of 6 patents)

9. Eva Walczyk (2 out of 2 patents)

10. Sheila Garven (2 out of 2 patents)

11. Phyllis Krygsman (2 out of 2 patents)

12. Cheryl Davey (2 out of 5 patents)

13. Genevieve Delcuve (2 out of 2 patents)

14. Jody Berry (1 out of 3 patents)

15. Darrell Johnstone (1 out of 3 patents)

13 patents: Sort by Forward Citations

1. 9994630 - Clostridium difficile antibodies (2018-06-12),

2. 6271344 - Enhanced affinity hyaluronan binding peptides (2001-08-07),

3. 6127144 - Method for expression of proteins in bacterial host cells (2000-10-03),

4. 5993812 - Method of delaying the progression of an infection with the human (1999-11-30),

5. 5985607 - Recombinant DNA molecules and expression vectors for tissue plasminogen (1999-11-16),

6. 5888774 - Recombinant DNA molecules and expression vectors for erythropoietin (1999-03-30),

7. 5856166 - Streptomyces proteases and methods for improved secretion of (1999-01-05),

8. 5641663 - Expression system for the secretion of bioactive human granulocyte (1997-06-24),

9. 5616485 - Streptomyces proteases and improved streptomyces strains for expression (1997-04-01),

10. 5514590 - Expression system comprising DNA encoding the signal peptide of protease (1996-05-07),

11. 5409818 - Nucleic acid amplification process (1995-04-25),

12. 5200327 - Expression system for the secretion of bioactive human granulocyte (1993-04-06),

13. 5130238 - Enhanced nucleic acid amplification process (1992-07-14),

Cangene Corporation is a biopharmaceutical company that specializes in the development and manufacture of biopharmaceutical products for the prevention and treatment of infectious diseases. With a focus on research and development, Cangene has a track record of bringing innovative products to market to address critical public health needs. The company is committed to improving the lives of patients around the world through the development of novel therapeutics and vaccines.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

13 Patents

#11 in Winnipeg

#1,108 in Canada

#43,635 in the World

Winnipeg, Canada

Cangene Corporation

Forward Citations = 1,484

25 inventors:

Lawrence T Malek (8 out of 14 patents)

David L Jenish (3 out of 3 patents)

Michael J Butler (3 out of 3 patents)

4. Gisela Soostmeyer (3 out of 3 patents)

5. Timothy J Krieger (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…